Intermountain Ventures
CVC
Active
Salt Lake City, United States
12
48M
10
3.00
1
0.17
2
- Areas of investment
Summary
Intermountain Ventures appeared to be a CVC structure as part of the corporation.
The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Intermountain Ventures, startups are often financed by U.S. Venture Partners (USVP), Norwest Venture Partners, Sanofi-Genzyme BioVentures.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. Among the various public portfolio startups of the fund, we may underline Omada Health
Investor highlights
- Industry focus
- Stage focus
- Check size
- 1M — 5M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 3.00
- Follow on index
- 0.17
- Investments by industry
- Health Care (11)
- Biotechnology (4)
- Medical Device (3)
- Health Diagnostics (3)
- Information Technology (3) Show 19 more
- Investments by region
-
- United States (12)
- Peak activity year
- 2020
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 480M
- Group Appearance index
- 0.92
- Avg. company exit year
- 15
- Avg. multiplicator
- 1.65
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Noetik | 07 Sep 2023 | Biotechnology, Life Science | Seed | 14M | United States, California, South San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.